2022
DOI: 10.1007/s42452-021-04928-3
|View full text |Cite
|
Sign up to set email alerts
|

Development, preparation and characterization of chitosan, gelatin and heparin membranes for biomedical applications

Abstract: With the rising in life expectancy and the consequent population aging, degenerative chronic diseases have been figured as the major cause of morbidity and mortality in the world. It is believed that the production of a polymeric matrix composed of chitosan and gelatin may be an alternative to obtain a carrier base of heparin, with the prospective objective of applying these materials as an alternative to the conventional therapeutic resources biomedical. Based on the results, it can be concluded that the inte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 15 publications
0
3
0
Order By: Relevance
“…The shells of marine animals containing chitin are deacetylated, which eventually becomes chitosan. Chitosan is used to increase the viscosity and stability by forming a dense network [8] [9]. Hou reinforces this, Wang who researched chitosan as an asphalt emulsifier, showing that chitosan can increase the viscosity of asphalt emulsions without adverse effects on stability [8].…”
Section: Introductionmentioning
confidence: 86%
“…The shells of marine animals containing chitin are deacetylated, which eventually becomes chitosan. Chitosan is used to increase the viscosity and stability by forming a dense network [8] [9]. Hou reinforces this, Wang who researched chitosan as an asphalt emulsifier, showing that chitosan can increase the viscosity of asphalt emulsions without adverse effects on stability [8].…”
Section: Introductionmentioning
confidence: 86%
“…A standard curve at different concentrations of rhodamine was used to calculate the unknown concentration released at different time points. In vitro degradation study was performed using simulated body fluids (SBF) (ASTM F1635-04 ) [7] . For this microneedle patches were soaked in SBF solution and at different time points, samples were dried and weight was measured.…”
Section: Methods Detailsmentioning
confidence: 99%
“…Heparin is formed by repeating disaccharide units of 1 → 4-linked hexuronic acid and glucosamine saccharide residues. Heparin is used in the manufacture of membranes [167] or in the novel polyelectrolyte-scavenging method for biomedical applications [168]. This glycosaminoglycan has been proposed for the cystic fibrosis treatment, for neurodegenerative diseases, as an antimicrobial agent, and in the pancreatitis treatment [169].…”
Section: Heparinmentioning
confidence: 99%